section name header

Use and Dosing

Adult Dosingnavigator.gif

Severe systemic infections caused by susceptible organism

Orbital cellulitis [Non-FDA Approved]

Epiglottitis [Non-FDA Approved]

Pediatric Dosingnavigator.gif

Severe Systemic Infections

Neonates

Pediatric patients

Orbital cellulitis [Non-FDA Approved]

Epiglottitis [Non-FDA Approved]

Bacterial Meningitis [Non-FDA approved]

Pediatrics Pneumonia [Non-FDA Approved]


[Outline]

Indications

Contraindications

Black Box Warnings

Dosing Adjustment

Renal Dose Adjustment for Adults (Based on CrCl)

Hepatic Dose Adjustment

Warnings/Precautions

Cautions: Use cautiously in

Pregnancy/Breast Feeding

Pregnancy Category:C

Breastfeeding: Limited information indicates that vancomycin is excreted in breastmilk in low levels and it would not be expected to cause any adverse effects in breastfed infants. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 6 September 2010).

Adverse Reactions

Clinical Pharmacology

Half-life:

Brands and Availability

flag_usa32.png

US Trade Name(s)

US Availability

vancomycin (generic)

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

vancomycin (generic)

flag_uk32.png

UK Trade Name(s)

UK Availability

vancomycin (generic)

Vancocin

flag_australia32.png

Australian Trade Name(s)

Australian Availability

vancomycin (generic)

Vancocin CP


[Outline]

flag_usa32.pngflag_canada32.pngflag_uk32.pngflag_australia32.png

Classification

Antimicrobials

Antibiotics
Glycopeptides

Infectious Disease

Antibiotics
Glycopeptides